Study objective: In COPD, it has been shown that peripheral muscle dysfunction is a factor determining exercise intolerance. We examined the hypothesis that exercise capacity of patients with idiopathic pulmonary fibrosis (IPF) is, at least in part, determined by peripheral muscle dysfunction. Methods: Maximum oxygen uptake (V O 2 max) was evaluated in 41 consecutive patients with IPF, along with potential determinants of exercise capacity, both in the lungs and in the peripheral muscles. Key words: aerobic exercise; idiopathic pulmonary fibrosis; interstitial lung disease; peripheral muscle; quadriceps force; skeletal muscle
I
diopathic pulmonary fibrosis (IPF) is generally considered to be a chronic progressive disease with significant morbidity and mortality. 1, 2 As the disease progresses, patients become severely limited in their activity. The limitation is perceived to be due to exertional dyspnea, secondary to lung dysfunction.
Patients with interstitial lung disease (ILD) have significantly reduced maximum exercise capacity as manifested by a reduced maximum work rate and reduced maximum oxygen uptake (V o 2 max) achieved during exercise. 3 It has been reported that exercise capacity of patients with ILD significantly correlates with a number of resting pulmonary function variables such as vital capacity (VC), FEV 1 , total lung capacity (TLC), diffusion capacity for carbon monoxide (Dlco), and Pao 2 . 3, 4 However, these reports included a mixed group of ILDs, for example, sarcoidosis and collagen vascular diseases. 3, 4 IPF is a specific form of chronic fibrosing interstitial pneumonia limited to the lung. 2 Usual interstitial pneumonia is the histopathologic pattern that identifies patients with IPF. 2 Recently, IPF has become more narrowly defined based on pathologic diagnosis by surgical lung biopsy or clinical diagnostic criteria in the American Thoracic Society (ATS)/ European Respiratory Society (ERS) consensus statement. 2, 5 It became apparent that median survival of IPF cases is between 2.5 years and 3.5 years, which is significantly worse than that of other chronic interstitial pneumonias. 5 Considering the progressive nature of IPF and its poor prognosis, it is quite important to assess the exercise capacity of patients with IPF. However, there have been few reports that have studied mechanisms of exercise limitation in IPF.
COPD is the most commonly studied lung disease in terms of exercise limitation. Although the mechanism of exercise limitation in COPD is multifactorial, 6 skeletal muscle dysfunction is considered to be an important factor that can contribute to exercise intolerance. 7 Weakness of peripheral muscles, especially the quadriceps, often occurs in COPD, 8 and this peripheral muscle weakness correlates with their exercise limitation. 9, 10 Reduced quadriceps strength is also observed in patients with chronic heart failure. 11, 12 In addition, a correlation between quadriceps strength and exercise capacity has been reported. 12 Therefore, in considering the mechanisms of exercise limitation in patients with IPF, we hypothesized that peripheral muscle weakness may exist in patients with IPF and may contribute to exercise intolerance. Therefore, we assessed the peripheral muscle function of patients with IPF and examined how the weakness relates to exercise capacity.
Materials and Methods

Study Design
Forty-one consecutive patients with IPF were included. IPF was diagnosed by a physician using the diagnostic criteria in the ATS/ERS consensus statement. 2 Surgical lung biopsies were performed in 21 patients, and pathologic diagnosis of IPF was also based on the consensus statement. 2 Chest high-resolution CT showed typical manifestations of IPF 13 in all patients. Patients were excluded if they had any of the following: obstructive lung disease such as COPD or asthma, active coronary artery disease, or other severe comorbid illness. IPF was newly diagnosed in all patients enrolled in the study with IPF, and they had not received any treatment such as corticosteroids or cytotoxic agents. Patients who could not perform exercise testing on a cycle ergometer were excluded.
All patients underwent pulmonary function testing and incremental maximal exercise testing on a cycle ergometer. Respiratory muscle force and peripheral muscle force, as assessed by maximal handgrip force (HF) and maximal quadriceps force (QF), were measured. Arterial blood was obtained from all patients for gas analysis.
This report is based on a retrospective analysis of clinically indicated studies of patients with IPF performed in our laboratory. This analysis was approved by our local institutional review board.
Pulmonary Function Tests
All patients underwent spirometry (CHESTAC-55V; Chest; Tokyo, Japan), according to the method described in the ATS 1994 update. 14 TLC was obtained using helium dilution, and single-breath Dlco was also measured (CHESTAC-55V; Chest). The values for VC, TLC, and Dlco were related to predicted values. 15 
Respiratory Muscle Force
All patients underwent determination of maximal inspiratory pressure (Pimax) and maximal expiratory pressure (Pemax). Pimax was measured at residual volume, and Pemax was measured near TLC, according to the method proposed by Black and Hyatt 16 (Vitalopower KH-101; Chest). The highest value of at least three maneuvers was recorded and related to the predicted values. 16 
Peripheral Muscle Force
QF was measured using a dynamometer (Cybex II; Lumex; Bay Shore, NY). Peak torque (newton-meters) was measured in both legs during a maximal isokinetic knee extension maneuver with the hip in 90°flexion. The highest value of at least three maneuvers in each leg was recorded. HF was measured with a hydraulic hand dynamometer (Smedley's Dynamometer; TTM; Tokyo, Japan). Peak HF (newtons) was assessed with each hand with the shoulder and wrist in neutral position. The highest value of at least three maneuvers was recorded for each hand. QF and HF were related to predicted values that are age and gender specific. 9, 17 Exercise Capacity An incremental symptom-limited exercise test was performed on a cycle ergometer (Ergometer 232CXL; COMBI; Tokyo, Japan). After 2 min of unloaded cycling, the work rate was increased by 10 W/min until the subject could no longer continue. During the test, oxygen uptake, ventilation (Centaura-1; Chest), and transcutaneous oxygen saturation (Spo 2 ) were measured, and a 12-lead ECG was obtained. V o 2 max values were related to normal values. 18 Anaerobic threshold (AT) was measured by V-slope method and also related to normal values. 19 Peak tidal volume to inspiratory capacity ratio (Vt/IC), peak minute ventilation to maximal voluntary ventilation ratio (V emax/ MVV), and ventilatory equivalent for CO 2 (V e/V co 2 ) at endexercise and AT were also calculated. Patients were asked to rate their dyspnea every minute during the test, using the modified Borg scale, 20 and also asked to rate the source of exercise limitation at end-exercise.
Statistics
Pearson correlation coefficients (r) were determined to examine the degree of correlation among lung and muscle functional variables and exercise capacity. For the variables significantly related to exercise capacity, a stepwise multiple regression analysis was performed using V o 2 max as a dependent variable. Variables used in the model included pulmonary function, Dlco, respiratory and peripheral muscle force, Pao 2 , and Spo 2 . A p value of Ͻ 0.05 was considered significant. All values are presented as mean Ϯ SD.
Results
Patient Characteristics and Anthropometric and Pulmonary Function Data
As shown in Table 1 defect. There was a moderate reduction in diffusing capacity consistent with a pulmonary vascular disorder.
Exercise Performance
Exercise performance of these patients are shown in Table 2 . Mean V o 2 max (893 Ϯ 314 mL/min) shows poor exercise capacity in these patients; the reduction in exercise capacity is out of proportion to lung mechanical alterations. AT could be measured in 37 patients by V-slope method, and the mean value also shows poor exercise capacity. Peak Vt/IC was larger than V emax/MVV, indicating that a restrictive ventilatory limitation was greater than an obstructive limitation to exercise; however, the difference was not substantial. V e/V co 2 was high, indicating an increased ventilatory requirement for exercise.
Muscle Testing
Respiratory and peripheral muscle testing results are shown in Table 3 . Pimax (94 Ϯ 24% predicted) and HF (94 Ϯ 57% predicted) were generally in the normal range; however, reduced Pemax (68 Ϯ 17% predicted) and QF (65 Ϯ 15% predicted) was observed. A significant correlation was observed between Pimax and Pemax (r ϭ 0.55; p Ͻ 0.0001). HF and QF were also interrelated (r ϭ 0.31; p Ͻ 0.05). Pimax was also correlated with QF (r ϭ 0.32; p Ͻ 0.05) but not with HF (r ϭ 0.12; p ϭ 0.45). Pemax was correlated with QF (r ϭ 0.54; p Ͻ 0.001), but not with HF (r ϭ 0.19; p ϭ 0.23).
Correlates of Exercise Capacity
In single correlation analysis, V o 2 max was significantly related to VC (r ϭ 0.79; p Ͻ 0.0001), TLC (r ϭ 0.64; p Ͻ 0.0001), Dlco (r ϭ 0.64; p Ͻ 0.0001), Pemax (r ϭ 0.48; p Ͻ 0.01), QF (r ϭ 0.62; p Ͻ 0.0001), and Pao 2 at rest (r ϭ 0.33; p Ͻ 0.05) [ Table 4 ]. Body weight (r ϭ 0.54; p Ͻ 0.001) and height (r ϭ 0.45; p Ͻ 0.01) were also significantly correlated with V o 2 max. A subgroup analysis was performed according to whether patients stated at the end of the exercise test that exercise was limited by dyspnea (n ϭ 27) or leg fatigue (n ϭ 14) [ Table 4 ]. In the subgroup limited by dyspnea, Pemax (r ϭ 0.52; p Ͻ 0.01), Pao 2 (r ϭ 0.40; p Ͻ 0.05), and V e/V co 2 at end-exercise (r ϭ Ϫ0.54; p Ͻ 0.01) were significantly related to V o 2 max; in the subgroup limited by leg fatigue, these lung function variables were not significantly predictive of exercise tolerance. However, HF (r ϭ 0.67; p Ͻ 0.01) was significantly related to V o 2 max only in patients who ended the exercise because of leg fatigue. If exercise capacity is assessed by AT, similar results were obtained (Table 5) .
In stepwise multiple regression analysis in the group as a whole, VC, QF, and V e/V co 2 at endexercise were independent predictors of V o 2 max (r 2 ϭ 0.71; p Ͻ 0.0001). In patients who terminated the exercise because of dyspnea, VC, QF, and resting Pao 2 values were significant contributing variables for V o 2 max (r 2 ϭ 0.71; p Ͻ 0.0001). In patients who stopped the exercise because of leg fatigue, VC and QF were significant contributing variables for V o 2 max (r 2 ϭ 0.69; p Ͻ 0.001) [ Table 6 ]). If AT is used as the measure of exercise tolerance in the group as a whole, VC, Dlco, and QF were independent predictors (r 2 ϭ 0.65; p Ͻ 0.001). In patients who terminated the exercise because of dyspnea, VC and Dlco were significant contributing variables for AT (r 2 ϭ 0.63; p Ͻ 0.001). In patients who stopped the exercise because of leg fatigue, QF and V e/V co 2 at AT were significant contributing variables for AT (r 2 ϭ 0.68; p Ͻ 0.001) [ Table 7 ]. A significant correlation was observed between dyspnea assessed by the Borg scale at the endexercise and QF (r ϭ 0.37; p Ͻ 0.05). However, in a subgroup who terminated the exercise due to dyspnea, no significant correlation was observed (r ϭ 0.08; p ϭ 0.69) between the two; whereas in a subgroup who stopped due to leg fatigue, a significant correlation was found (r ϭ 0.62; p Ͻ 0.05).
Discussion
In the present study, we found that QF is reduced in patients with IPF, and this weakness correlates with exercise limitation as well as lung function impairment in those patients. Among these variables, VC and QF were particularly significant contributing factors according to the stepwise analysis. To our knowledge, this is the first report clarifying the relationship between peripheral muscle performance and exercise capacity in patients with IPF.
Some factors and mechanisms that determine exercise capacity in ILD have been reported, although those in IPF have not been extensively studied. A decrease in exercise capacity has been reported even in ILD patients who have normal resting pulmonary function results. 4 Thus, directly measuring exercise capacity of patients with ILD is important in evaluating impairment. Factors reported to correlate with exercise limitation in patients with ILD include VC, FEV 1 , TLC, Dlco, and, possibly, Pao 2 . 3,4 Mechanism of exercise limitation in patients with ILD has also been explored. Marciniuk et al 21 described expiratory flow limitation in all patients who stopped exercise due to dyspnea. In the remaining patients who discontinued exercise because of leg fatigue, no flow limitation was evident. 21 Harris-Eze et al 22 reported that patients with ILD were able to increase both peak ventilation and exercise performance with supplemental oxygen. This finding suggests a hypothesis that arterial hypoxemia, not ventilatory limitation, limits exercise. As another contributing factor, ventilation-perfusion mismatching, may contribute to exercise limitation. 4, 23, 24 Diffusion limitation and circulatory limitation can also affect exercise tolerance of patients with ILD. Hansen and Wasserman 4 reported that Dlco was the best correlate of V o 2 max in ILD. It is also suggested that higher respiratory drive during exercise can be attributed to increased afferent reflexes originating from the lung or chest wall, which might thereby limit exercise tolerance. 25 Despite these previous studies, 3, 4, [21] [22] [23] [24] [25] the pathophysiology of exercise limitation in ILD has been inadequately elucidated. Moreover, studies that investigated mechanisms of exercise limitation in patients with ILD generally included a variety of diseases, such as idiopathic interstitial pneumonia, sarcoidosis, and collagen vascular diseases. It seems likely that the factors that determine exercise limitation depend on the etiologies of ILD. Thus, our evaluation of exercise capacity in one disease, IPF, seems valuable. Furthermore, the fact that the QF is decreased and is a significant correlate of exercise capacity in IPF seems to be important in elucidating the mechanism of exercise limitation in the disease.
In the present study, a marked decrease in V o 2 max was observed in patients with IPF, even if impairment in lung function was not so severe as has been reported in some previous studies. 3, 4, [21] [22] [23] [24] [25] Moreover, lung function including VC, TLC, and Dlco significantly correlated with V o 2 max. Pao 2 and V e/V co 2 at the end of exercise significantly correlated with V o 2 max in patients who terminated the exercise due to dyspnea, but not in those who stopped due to leg fatigue. This is consistent with the concept that respiratory limitation contributes to limitation of exercise capacity in patients who stopped the test because of dyspnea. Even in those patients, QF was a strong correlate of V o 2 max. If exercise capacity is assessed by AT, similar results were obtained. This supports the importance of QF as a determinant of exercise capacity in IPF. Moreover, a significant correlation between dyspnea at end-exercise and QF indicates that the quadriceps limitation is less than that in those patients who are more tolerant of the discomfort of dyspnea. The decreased compliance of the lungs in IPF imposes a chronic load on the muscles of inspiration. As a result, these muscles are likely to be quite "fit," possibly explaining the normal Pimax values. In contrast, expiration is likely to be passive under almost all conditions, resulting of relative deconditioning of the expiratory muscles, possibly explaining the low Pemax values observed.
The pathophysiology underlying quadriceps weakness that was observed in the present study is not yet known. One possible mechanism is deconditioning due to limitation in activities of daily living. The normal HF observed in the study may be explained in that hand strength may not respond to decreased activity to the same degree as the quadriceps. Another possible mechanism of quadriceps weakness is related to the inflammatory disease process of IPF. Other possible mechanisms include decreased levels of anabolic hormones and myopathy specific to IPF, similar to that reported in COPD. 26 Clearly, additional research will be necessary to elucidate the pathophysiology of the muscles of ambulation in IPF.
The ATS/ERS consensus statement recommends therapeutic trial of corticosteroid therapy in patients with IPF. 2 Myopathy induced by corticosteroids has been reported to enhance peripheral muscle weakness in these patients. 27 Myopathy of respiratory muscle reportedly can occur from the use of corticosteroids, 28 which can potentially affect the exercise tolerance of patients. However, these factors were not present in this study because subjects had not been treated with corticosteroids.
In our study, exercise-induced desaturation did not correlate with V o 2 max, possibly because only patients with mild-to-moderate impairment in lung function were enrolled, and desaturation was only mild.
The results of the present study imply that the training of peripheral muscles, especially in the lower extremities, might increase exercise capacity of patients with IPF. In COPD, training of the lower extremities is the most important factor in pulmonary rehabilitation. 29, 30 Although Foster and Thomas 31 demonstrated the efficacy of pulmonary rehabilitation for non-COPD patients, there are few reports about pulmonary rehabilitation for patients with ILD including IPF. Although pulmonary rehabilitation has not yet been shown to be effective for patients with ILD, our results suggest the possibility of the efficacy of pulmonary rehabilitation for IPF.
Hence, the role of pulmonary rehabilitation for patients with IPF should be evaluated in additional studies, including the training of peripheral muscles.
There are some limitations in this study. First, we included only patients with mild-to-moderate lung impairment (VC, 76.6 Ϯ 16.8%). This was because patients with a new diagnosis were studied because we wished to avoid the confounding effects of pharmacotherapy for IPF on the muscles. So, it is unclear whether our results can be applied to more severe cases. Secondly, not all patients received a diagnosis pathologically. Some reports, 13, 32 however, have demonstrated that the accuracy of thin-section CT in identifying IPF is quite high. The patients receiving a diagnosis of IPF clinically and included in the study are unlikely to have other ILD.
In conclusion, both measures of pulmonary function and of QF significantly correlate with exercise capacity in patients with IPF. VC, QF, and V e/V co 2 at peak exercise are independent predictors of exercise capacity in patients with IPF.
